AustinPx Wins Innovation Award For KinetiSol™ Technology
22 Oct 2024 //
BUSINESSWIRE
AustinPx Invests in Pharmaceutics & Capabilities to Accelerate Drug Development
08 Apr 2024 //
BUSINESSWIRE
Elizabeth Hickman to Succeed Tim Scott as AustinPx CEO
05 Mar 2024 //
BUSINESSWIRE
AustinPx Partners with Microsize on KinetiSol® Technology
31 Jan 2024 //
BUSINESSWIRE
AustinPx Expands Development and Manufacturing Technologies
09 May 2023 //
BUSINESSWIRE
AustinPx Names Derek Hennecke and Marshall Crew to its Board of Directors
18 Oct 2022 //
BUSINESSWIRE
AustinPx Names Elizabeth Hickman Chief Business Officer
27 Sep 2022 //
BUSINESSWIRE
DisperSol, Ajax Collaborate to Develop Enhanced KinetiSol Drug Formulations
17 Dec 2021 //
BUSINESSWIRE
DisperSol, Catalent Ink Pact to Build KinetiSol® Technology Manufacturing Hub
02 Aug 2021 //
PRESS RELEASE
DisperSol Technologies Names David Snyder as Chief Financial Officer
24 Sep 2020 //
BUSINESSWIRE